714
Views
17
CrossRef citations to date
0
Altmetric
Author's View

Breaking tumor-induced immunosuppression with 5′-triphosphate siRNA silencing TGFβ and activating RIG-I

&
Article: e24170 | Received 28 Feb 2013, Accepted 28 Feb 2013, Published online: 01 May 2013

References

  • Massagué J. TGFbeta in Cancer. Cell 2008; 134:215 - 30; http://dx.doi.org/10.1016/j.cell.2008.07.001; PMID: 18662538
  • Moutsopoulos NM, Wen J, Wahl SM. TGF-beta and tumors--an ill-fated alliance. Curr Opin Immunol 2008; 20:234 - 40; http://dx.doi.org/10.1016/j.coi.2008.04.003; PMID: 18486463
  • Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 2010; 31:220 - 7; http://dx.doi.org/10.1016/j.it.2010.04.002; PMID: 20538542
  • Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, et al. A critical function for type I interferons in cancer immunoediting. Nat Immunol 2005; 6:722 - 9; http://dx.doi.org/10.1038/ni1213; PMID: 15951814
  • Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 2006; 314:994 - 7; http://dx.doi.org/10.1126/science.1132505; PMID: 17038590
  • Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, Wenzel M, et al. 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 2009; 106:12067 - 72; http://dx.doi.org/10.1073/pnas.0900971106; PMID: 19574455
  • Besch R, Poeck H, Hohenauer T, Senft D, Häcker G, Berking C, et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 2009; 119:2399 - 411; PMID: 19620789
  • Poeck H, Besch R, Maihoefer C, Renn M, Tormo D, Morskaya SS, et al. 5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat Med 2008; 14:1256 - 63; http://dx.doi.org/10.1038/nm.1887; PMID: 18978796
  • Yoneyama M, Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 2009; 227:54 - 65; http://dx.doi.org/10.1111/j.1600-065X.2008.00727.x; PMID: 19120475
  • Ellermeier J, Wei J, Duewell P, Hoves S, Stieg MR, Adunka T, et al. Therapeutic efficacy of bifunctional siRNA combining TGF-beta1 silencing with RIG-I activation in pancreatic cancer. Cancer Res 2013; In press http://dx.doi.org/10.1158/0008-5472.CAN-11-3850; PMID: 23338611